Furthermore, the present study for the first time shows that pharmacological inhibition of MDM2 (which increased protein expression of RXRβ) attenuates the development of atherosclerosis and reverses mitochondrial damage and the related inflammation in this process. This evidence concerns the gene RXRB and atherosclerosis.